234
LIGA.net, March 21, 2025The extension of patents for the period of martial law creates obstacles to the timely entry of new medicines into the Ukrainian market.
499
Bolar Exemption allows generic drug manufacturers to start marketing authorization process for a medicinal product before the patent for the generic medicinal product expires.
1078
Recently, the Ukrainian Bar Association (UBA) Committee held a meeting on the topic ‘Ukrainian Bolar: efficiency and ways to improve’.
1466
Apteka.ua, 24.10.2024Read more (in Ukrainian)
1017
Dmytro Aleshko, managing partner of LA Law Firm, took part in the forum as a speaker. - The results of the forum, Apteka.ua
1000
LA Law Firm held the webinar highlighting key regulatory changes in the pharmaceutical sector, in particular in the Health Technology Assessment (HTA) procedure, Managed Entry Agreement (MEA), parallel import, regulatory changes in the circulation of dietary supplements, etc.
1061
The publishing house "Yuridychna Praktika" announced the twenty-first issue of Ukrainian Law Firms. A Handbook for Foreign Clients
704
We continue to inform our readers about the events of the annual XIII Congress "Pharmacies of the World-2024", which took place in Kyiv with the participation of more than 300 pharmaceutical professionals from all over Ukraine and abroad.
1359
This year's WWL: Life Sciences once again recognized LA Law Firm managing partner among the leaders.
1133
The pharmaceutical market is always in the focus of attention of the Antimonopoly Committee of Ukraine (AMCU) due to its social importance. A number of specific features of this market add additional challenges.
